This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here.

Close Message
NextPharmaJob.com for pharmaceutical industry jobs
Envision your future with us
NextPharmaJob.com is dedicated to putting job seekers looking for pharmaceutical industry jobs in touch with recruiters and employers.
Browse Jobs Search Jobs

To receive a FREE weekly email alert of all the latest pharmaceutical industry jobs added to our database enter your email address below.

Submit | Tell me more...

Sister sites:
Our sister site Our sister site
Partner sites:

At Burntsky Limited we work with a number of third parties in order to maximise the reach of the jobs posted with us including but not limited to:

JooblePartner Jooble
UK Jobs
Science Jobs

Industry News
22 November 2019 15:42Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corporation (ARTX) to Contact Firm
NEW YORK, Nov. 22, 2019 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary dutie

22 November 2019 13:15Varian Updates GAAP Results for Fourth Quarter and Full Fiscal Year 2019
PALO ALTO, Calif., Nov. 22, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced updates to its previously reported GAAP preliminary financial results for its fourth quarter and full fiscal year 2019. There is no impact to Non-GAAP financial mea

22 November 2019 13:00Santen Receives CADTH Canadian Drug Expert Committee (CDEC) Reimbursement Recommendation for Verkazia(TM) (cyclosporine 0.1%) Eye Drops
TORONTO, Nov. 22, 2019 /PRNewswire/ -- Santen Canada Inc., a subsidiary of Santen Pharmaceutical Co., Ltd. ("Santen" TSE: 4536), a global company focused exclusively on ophthalmology, announced that the Canadian Agency for Drugs and Technologies in

22 November 2019 12:00Regeneron's Yancopoulos Receives Columbia College's Alexander Hamilton Award
TARRYTOWN, N.Y., Nov. 22, 2019 /PRNewswire/ -- Columbia's highest honor bestowed for Yancopoulos' contributions to science and medicine Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that George D. Yancopoulos, M.D., Ph.D., Co-Found

22 November 2019 11:30Solvent Evaporation Market Worth $694 Million by 2024 - Exclusive Report by MarketsandMarkets™
CHICAGO, Nov. 22, 2019 /PRNewswire/ -- According to the new market research report "Solvent Evaporation Market by Evaporator Type (Rotary Evaporator, Nitrogen Blow Down Evaporator, Centrifugal Evaporator), End-Use (Pharmaceutical & Biopharmaceu

22 November 2019 08:50The 13th Edition of CPhI & P-MEC India Expo Gears up to Script the Growth Story of Global Pharma Industry
- South Asia's largest Pharma event to kick start at the India Expo Mart - Greater Noida, with all its attendant facilities from 26th November- 28th November -The expo that unites the entire Pharma value chain received overwhelming participation r

21 November 2019 03:19Thrombosis Research Institute (TRI) stellt innovativen Risikoberechner zur Vorhersage von Schlaganfall, starken Blutungen und Mortalität bei Vorhofflimmern über einen Zeitraum von zwei Jahren vor
- Schnelles Vorhersagen von Risikounterschieden bei Behandlung mit verschiedenen Antikoagulanzien oder bei Nichtbehandlung  - Entscheidend ist, dass das Risiko nicht mit standardisierten, sondern mit patientenspezifischen Messungen berechnet wird,

21 November 2019 03:16Le Thrombosis Research Institute (TRI) lance un calculateur de risque innovant pour la prévision sur deux ans des accidents vasculaires cérébraux, des hémorragies graves et de la mortalité des patients atteints de fibrillation atriale
- Il permet de prédire rapidement les variations de risque en fonction du traitement ou non des patients avec divers anticoagulants - Le risque est essentiellement calculé sur la base de mesures spécifiques au patient plutôt que de mesures standard

21 November 2019 02:57Cambridge Quantum Computing Capai Keputusan Rintis dalam Kimia Kuantum
CQC membolehkan VQE beroperasi dan sediakan laluan yang cekap ke arah mensimulasikan molekul teruja menggunakan komputer kuantum CAMBRIDGE, England, 22 November 2019 /PRNewswire/ -- Cambridge Quantum Computing ("CQC") hari ini mengumumkan satu pe

21 November 2019 01:31Willow Biosciences Reports Third Quarter 2019 Results and Provides Operations Update
CALGARY, Nov. 21, 2019 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW, OTCQB: CANSF) has released its financial and operating results for the three and nine months ended September 30, 2019. "Over the past few months,

21 November 2019 23:10FDA Approves XCOPRI® (cenobamate tablets), an Anti-Epileptic Drug (AED) from SK Biopharmaceuticals, Co., Ltd., and U.S. Subsidiary SK Life Science, Inc.
PANGYO, South Korea and PARAMUS, N.J., Nov. 21, 2019 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., an innovative global pharmaceutical company focused on developing and bringing treatments to market for central nervous system (CNS) disorders, a

21 November 2019 22:31CNS Pharmaceuticals Announces Full Exercise of Over-Allotment Option
HOUSTON, Nov. 21, 2019 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("Company"), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced the closing of the issuance of an additional

21 November 2019 22:14FDA approves new treatment for adults with partial-onset seizures
SILVER SPRING, Md., Nov. 21, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved XCOPRI (cenobamate tablets) to treat partial-onset seizures in adults. "XCOPRI is a new option to treat adults with partial-onset seizures

21 November 2019 22:00CannTrust Provides Default Status Report
VAUGHAN, ON, Nov. 21, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) today is providing a status update in accordance with its obligations under the alternative information guidelines set out in Na

21 November 2019 21:04BioMarin Submits Marketing Authorization Application to European Medicines Agency for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A
SAN RAFAEL, Calif., Nov. 21, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the company submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its investigational gene

21 November 2019 21:00CEO Jason Longden Announces Pasha Brands Focused on Commercializing Pre-roll Brands
VANCOUVER, British Columbia    , Nov. 21, 2019 /PRNewswire/ -- Pasha Brands Ltd. ("Pasha or the Company") (CSE: CRFT) (OTC: CRFTF) (FSE: ZZD), Canada's largest craft cannabis brands organization, has responded to both the contraction in the capital

21 November 2019 20:31IRRAS Announces FDA Clearance of New 510(K) Filing to Expand the Time of Use of IRRAflow®
STOCKHOLM, Nov. 21, 2019 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today that the US FDA has cleared a new 510(K) for IRRAflow. The application provide

21 November 2019 19:31Elios Therapeutics Presents Primary Analysis of Phase IIb Study Showing Personalized Cancer Vaccine Significantly Reduces Risk of Melanoma Recurrence in High-Risk Patients
AUSTIN, Texas, Nov. 21, 2019 /PRNewswire/ -- Elios Therapeutics, a biopharmaceutical company developing innovative personalized therapeutic cancer vaccines, today announced that the Company presented the primary analysis of the prospective, randomi

21 November 2019 19:22INTERCURE: CANNDOC Initiates Phase 3 Clinical Trial Evaluating Pharma Grade Medicinal Cannabis (CANNDOC T1/C20) For Children With Autism Spectrum Disorder
HERZLIYA, Israel, Nov. 21, 2019 /PRNewswire/ -- Israeli medical cannabis company InterCure Ltd. (TASE: INCR) announced that its wholly-owned subsidiary Canndoc initiated a phase 3 clinical trial with the Shamir Medical Center (Assaf HaRofeh) for t

21 November 2019 17:55Former French Secretary of State joins Eagle Genomics' Board of Directors
- Delphine Gény-Stephann, former French Secretary of State, joins Eagle Genomics' board of directors - A champion of industry and innovation, Delphine is appointed as a non-executive director - Bringing a wealth of experience, she will contribute
News last updated 22/11/2019 17:13:00
line graphic

Compatible with:

JobMate   Broadbean   Idibu

Site optimised for Internet Explorer 8+ / Firefox 3+
View a complete Jobs Listing




Credit cards image